The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • See Evidence submitted by expert panel for details.

Variant: NM_030662.3(MAP2K2):c.1112G>A (p.Arg371Gln)

CA296157

40842 (ClinVar)

Gene: MAP2K2
Condition: RASopathy
Inheritance Mode: Autosomal dominant inheritance
UUID: 58e61181-b2bb-4f50-9d9a-4c506757fc9d
Approved on: 2019-08-26
Published on: 2019-10-02

HGVS expressions

NM_030662.3:c.1112G>A
NM_030662.3(MAP2K2):c.1112G>A (p.Arg371Gln)
NC_000019.10:g.4090689C>T
CM000681.2:g.4090689C>T
NC_000019.9:g.4090687C>T
CM000681.1:g.4090687C>T
NC_000019.8:g.4041687C>T
NG_007996.1:g.38440G>A
ENST00000262948.9:c.1112G>A
ENST00000394867.8:c.821G>A
ENST00000597263.5:n.297G>A
ENST00000599021.1:n.222G>A
ENST00000600584.5:n.2561G>A
ENST00000601786.5:n.1413G>A
More

Uncertain Significance

Met criteria codes 2
PP2 BP5
Not Met criteria codes 9
PS1 PS4 PM2 PM5 PM1 BA1 BS1 BS4 BP4

Evidence Links 1

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
RASopathy VCEP
The p.Arg371Gln variant in MAP2K2 has been identified in 0.00401% (lower bound of the 95% CI of 7/81796) of non-Finnish European chromosomes in gnomAD (https://gnomad.broadinstitute.org) (BS1 not met). Computational prediction tools and conservation analyses do not provide strong support for or against an impact to the protein. The variant is located in the MAP2K2 gene, which has been defined by the ClinGen RASopathy Expert Panel as a gene with a low rate of benign missense variants, and pathogenic missense variants are common (PP2; PMID: 29493581). This variant has been observed in many individuals with varying clnical presentations that lack clear associations with a RASopathy. This variant was identified in 1 individual with syncope and atrial fibrillation, who carried an additional pathogenic variant in a cardiomyopathy gene sufficient to explain their clinical presentation (BP5; Invitae internal data). In summary, the clinical significance of this variant is uncertain. ACMG/AMP Criteria applied: PP2, BP5.
Met criteria codes
PP2
MAP2K is a missense-constrained gene
BP5
Invitae internal data includes 1 proband (teenaged female) with syncope and atrial fibrillation who has a pathogenic variant in a cardiomyopathy gene
Not Met criteria codes
PS1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PS4
Internal data from Invitae includes 4 patients with this variant: 1 teenaged female with syncope and atrial fibrillation who had a pathogenic variant in a cardiomyopathy gene, 1 infant female with widely spaced nipples and posterior neck fold, 1 male in his 50's with HCM, and 1 female in her 30's with tricuspid atresia. 1 proband from Bhoj et al. Integrated internal data: seen in the heterozygous state in 2 probands without other clinical information. GeneDx classified as LB based on frequency, in silico predictors, and failure to segregate with phenotype in 1 family (did not specify phenotype). None of these cases were counted due to inconsistent phenotypes.

PM2
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
PM5
One other variant reported in ClinVar, but VUS.
PM1
Mutation does not occur within residues 47-65 or 128-38.
BA1
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
BS1
Identified in 0.00401% (lower bound of the 95% CI of 7/81796) of non-Finnish European chromosomes in gnomAD
BS4
GeneDx reports 1 failure to segregate, but does not provide phenotype
BP4
No impact to splicing. REVEL score 0.341. No other mammals have Gln at this site.
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.